Immune Checkpoint Inhibition by Anti-Pdcd1 (Anti-Pd1) Monoclonal Antibody Has Significant Therapeutic Activity Against Central Nervous System Lymphoma in an Immunocompetent Preclinical Model
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15009
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 26, 2017
Authors
Publisher
Wiley